The biosynthesis of the antitumor antibiotic, CC-1065, has been investigated by radioactive isotope techniques, in combination with chemical degradation of CC-1065. Tyrosine, dopa, serine and methionine (S-CH3 group) have been shown to be precursors of CC-1065. Tyrosine is proposed to be a precursor of all three benzodipyrrole subunits, while dopa is only apparently incorporated into subunits B and C. Serine is postulated to contribute three 2C units, with loss of C-1, to all three subunits of CC-1065. The S-CH3 group of methionine probably contributes four C-1 units to CC-1065 of which one is incorporated with considerable loss of tritium, most probably into the cyclopropane ring of subunit A.
Nonlabelled Compounds CC-1065 (U-56,314, lot No. 15168-DGM-33.17) was obtained from Dr. DAVID MARTIN at the Upjohn Company and dissolved in 5 % DMF in water prior to use. The methylpyrrole compound (4-methylpyrrole-2,3-dicarboxylic acid) used in the Kuhn-Roth oxidation was obtained from Dr. KOSTENBAUDER at the University of Kentucky.
Isotope Analysis Radioactivity measurements were carried out on Packard Model 2425 liquid scintillation counter. Radioactive samples were added to 8 ml of Aquasure and counted to at least 2 % statistical error and counting efficiencies were determined using an external standardization method. Radioactivity on chromatograms was detected using a Packard Model 7201 radiochromatogram scanner.
Chromatography Thin-layer chromatography on 5 x 20 cm precoated Silica gel 60 F-254 was used throughout this study. Visualization of CC-1065 was by short UV light in which CC-1065 produced a blue fluorescence. Chromatography systems consisted of methylethylketone -acetone -water, 80: 17: 3 ; CC-1065 Rf 0.66 (TLC-1) and chloroform -methanol -ammonium hydroxide, 80: 20: 0.5; CC-1065 Rf 0.56 (TLC-2).
Sephadex G-100 column chromatography on the CC-1065-DNA adduct was carried out in 5 ml syringes (about 1 -2 ml of Sephadex) and eluted with water. Although adduct formation with DNA and then Sephadex chromatography will eliminate non-DNA reactive compounds, other CC-1065 degradation products still containing the DNA alkylating moiety will not be removed. CC-1065-DNA adduct were prepared by incubation of the isolated CC-1065 dissolved in 450 , d of 0.1 SSC, with an excess of calf thymus DNA (62 Egg in 50 I41 of 0.1 SSC) at 4°C overnight. 1 ml fractions were collected and 200 p1 used for liquid scintillation counting in 8 ml of Aquasure and the remaining 800 p1 used for O.D. measurements at 260 nm (DNA) and 363 nm (CC-1065). The CC-1065-DNA eluted in fractions 2'4 and fraction 3 was used for radioactivity determinations.
Isolation n of CC-1065 from Cultures and Determination of Percentage Incorporation of Precursors At the end of the incubation period after adjusting the pH of the broth to 10 with concentrated NH4OH, the whole fermentation broth is extracted twice with 200 ml of methylene chloride. The organic layers are pooled, dried over anhydrous sodium sulfate and taken to dryness on a rotary evaporator at 40°C. The residue is redissolved in acetone (about 3 ml) and 10 pd taken for radioactivity determination. An aliquot equivalent to about 2 x 104 dpm (14C) or 2 x 105 dpm (3H) is spotted on a TLC plate alongside reference CC-1065 and developed in TLC-l. The CC-1065 is located on the developed plate by exposure to UV light. The plate was then scanned for radioactivity using a radiochromogram scanner and the percentage incorporation determined from the combined radioactivity and scanning results as previously described'). Those samples found to be significantly labelled in TLC-1 were further purified by scraping off the band corresponding to CC-1065 rechromatographing in TLC-2 and Sephadex G-100 system to check for radiochemical purity.
Degradation of CC-1065 by Kuhn-Roth Oxidation Radiochemically pure samples of CC-1065 labelled from methionine and serine were degraded by Kuhn-Roth oxidation'). Due to the unavailability of significant amounts of carrier CC-1065, a methylpyrrol compound was used as a carrier material (100 mg) since it carries an equivalent C-CH, group in a pyrrole ring. The acetic acid obtained from the Kuhn-Roth oxidation was isolated and counted for radioactivity.
Results

Determination of the Biosynthetic Precursors for CC-1065
CC-1065 consists of three very similar benzodipyrrole subunits (A, B, and C in Fig. 1 ) of which B and C are identical and subunit A is distinguished by having an extra carbon atom incorporated into a cyclopropane ring and also containing an indole quinone in place of a dihydroxyindole moiety. Based upon biosynthetic considerations it seemed most likely that the indole ring of tryptophan or cycli- Substrate fed The results of radioisotope tracer experiments are shown in Table I and demonstrate that of the suspected precursors fed, only tyrosine, dopa, serine and methionine were detectable incorporated into CC-1065. Scarcity of cold carrier material precluded recrystallization to constant specific activity, however, the isolated biosynthetically labelled CC-1065 was shown to be radiochemically pure by both chromatography in two TLC systems and then binding to DNA which was then purified by Sephadex 
Incorporation of Dopa into CC-1065
The incorporation of dopa into CC-1065 (see Table 1 ) could be explained by its sole incorpora Species fed tion into subunits B and C (see Fig. 3 ), which would rationalize the hydroxylation pattern in the six membered rings. If tyrosine, but not dopa, is a precursor of subunit A this would strongly support pathway "a" in Fig. 2 Table 2 demonstrate that both carbon-14 labels are incorporated to almost the same extent. This result is consistent with dopa not being incorporated into subunit A. Consequently pathway "a" in which tyrosine but not dopa is an intermediate is supported by these experiments.
The retention of between 28 and 30% of tritium from L-[Ala-2' or 3'-3Hldopa in CC-1065 may have some significance in terms of the stereospecificity of elimination of one of the hydrogen atoms originally at 3' of dopa (and by inference tyrosine). The C-3' carbon of dopa should be located exclusively at C-17 and C-30 of subunit B and C respectively of CC-1065, both of which are methine carbons. Since C-2' of tyrosine is predicted to label C-16 and C-29 of CC-1065, which is a quaternary carbon in both cases the tritium must be lost from this position. The tritium labelling pattern in the side chain of phenylalanine and tyrosine prepared in a similar manner to the dopa used in this experiment has been shown by KIRBY3> to be as follows: First, the tritium is distributed equally between positions 2' and 3' of the side chain. Second, the tritium at C-3' of the side chain is predominantly in the pro-S position (41.5±0.5 %) relative to 8.5±0.5 % in the pro-R position. The 28' 30 % retention of tritium is in between that expected for loss of the pro-S hydrogen (8.5 % retention) or the pro-R hydrogen (41.5% retention). However, previous investigations',") have also revealed excess tritium and deuterium retentions in sibiromycin and gliotoxin respectively. By analogy with sibiromycin (19 retention of tritium) we would predict the stereospecific loss of the 3'-(R) hydrogen of dopa during its conversion of subunits B and C, however, until experiments with stereospecific labelled substrates and chemical degradation are carried out, this conclusion should only be very tentatively offered.
Incorporation of Serine into CC-1065
Based upon the results of double-labelling experiments with tyrosine and dopa we can predict that serine should label CC-1065 as shown in Fig. 4 . In this figure we proposed C-2 and 3 serine give rise to C-2 and 3 of subunit A and C-24 and 25 plus C-37 and 38 of subunits B and C respectively. A number of single, and double labelling experiments using serine in conjunction with chemical degradation of CC-1065 were designed and executed to test this postulate. Fig. 4 predicts that while the tritium at C-3 of serine should be retained at C-24 and C-37 of subunits B and C of CC-1065 respectively, the tritium should be lost in subunit A and furthermore C-1 of serine should not be incorporated into CC-1065. The results (experiments 7 and 8) in Table 2 Table  2 indicate an 69% retention of tritium in CC-1065. The less than 100% retention of tritium in CC-1065 is in accord with an additional C-1 unit, other than the three intact methyl groups found in subunits A (C-3'), B (C-20') and C (C-33'), which is incorporated with significant loss of tritium. Assuming that the C-I units contribute equally to each of the 4carbons in CC-1065 derived from methionine, . Therefore the tritium retention of 69 % is suggestive of a transfer of a C-i unit to the cyclopropane ring without any associated hydrogen. This latter result should, however, be treated with some caution since not only is this dependant upon the assumption that methionine labels each C-1 unit equally but that isotope effects are not operating during this transfer.
Kuhn-Roth oxidation of CC-1065 (see Fig. 4 ), biosynthetically labelled from L-[I4CH3]methionine yielded acetic acid possessing 22.5% of the total radioactivity of CC-1065. This is in reasonable agreement of the calculated 25 % that would be expected if methionine contributed four C-1 units all of which approximately equally labelled the CC-1065.
Discussion
The results of this study demonstrate that tyrosine, dopa, serine and methionine (C-1 units) are biosynthetic precursors of CC-1065. Our double-labelling experiments with these precursors provide a reasonable basis for the postulated biosynthetic labelling pattern of these amino acids in CC-1065 which is shown in Fig. 5 . This study also provides an example of how thoughtful experimental design can reveal much useful information on probably biosynthetic labelling patterns in a secondary metabolite, where stable isotope techniques have proven to be difficult to apply.
CC-1065 is produced in relatively low amounts (2 -4 mg/liter) in a complex media containing large amounts of amino acids in a fish meal extract. Experiments using radioactively labelled tyrosine and methionine reveal at best, dilution values of in excess of 500 which rules out the possibility of stableisotope experiments. Persistent efforts to develop a synthetic or semisynthetic media which will support production of more than trace amounts of CC-1065 have also so far failed. Likewise we have been unsuccessful in developing a washed cell suspension that will support antibiotic production, although possibly a resting cell system in which amino acids were limited but antibiotic synthetases were already formed prior to cell collection might be successful. Therefore, more definitive experiments with stable isotopes will have to await the isolation of CC-1065 producing strains with improved properties or fermentation conditions.
